Literature DB >> 25437293

Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.

Kimber Simmons1, Aaron W Michels2.   

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disorder resulting from immune-mediated destruction of insulin-producing beta cells within the pancreatic islets. Prediction of T1D is now possible, as having 2 or more islet autoantibodies confers a 100% risk of diabetes development. With the ability to predict disease development, clinical trials to prevent diabetes onset have been completed and are currently under way. This review focuses on the natural history, prediction, and prevention trials in T1D. We review the lessons learned from these attempts at preventing a chronic autoimmune disease and apply the paradigm from T1D prevention to other autoimmune disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Immune therapies; Prevention; Type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25437293      PMCID: PMC4250578          DOI: 10.1016/j.rdc.2014.07.008

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  75 in total

Review 1.  Understanding type 1 diabetes through genetics: advances and prospects.

Authors:  Constantin Polychronakos; Quan Li
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

2.  Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell.

Authors:  J Spencer; M Peakman
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

3.  Protection against alloxan diabetes.

Authors:  A LAZAROW
Journal:  Anat Rec       Date:  1947-03

4.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

5.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

6.  Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.

Authors:  J C Carel; C Boitard; G Eisenbarth; J F Bach; P F Bougnères
Journal:  J Autoimmun       Date:  1996-12       Impact factor: 7.094

7.  Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Authors:  Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell
Journal:  Lancet       Date:  2008-09-22       Impact factor: 79.321

8.  The use of nicotinamide in the prevention of type 1 diabetes.

Authors:  R B Elliott; C C Pilcher; A Stewart; D Fergusson; M A McGregor
Journal:  Ann N Y Acad Sci       Date:  1993-11-30       Impact factor: 5.691

Review 9.  The artificial pancreas: current status and future prospects in the management of diabetes.

Authors:  Thomas Peyser; Eyal Dassau; Marc Breton; Jay S Skyler
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

10.  Type 1 Diabetes TrialNet--an international collaborative clinical trials network.

Authors:  Jay S Skyler; Carla J Greenbaum; John M Lachin; Ellen Leschek; Lisa Rafkin-Mervis; Peter Savage; Lisa Spain
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more
  8 in total

Review 1.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

Review 2.  Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset?

Authors:  Manuela Battaglia; Laura Nigi; Francesco Dotta
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 3.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 4.  Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.

Authors:  Aaron Michels; Li Zhang; Anmar Khadra; Jake A Kushner; Maria J Redondo; Massimo Pietropaolo
Journal:  Pediatr Diabetes       Date:  2015-07-23       Impact factor: 4.866

Review 5.  New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.

Authors:  Aaron W Michels; David A Ostrov
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

6.  Population-based estimates of humoral autoimmunity from the U.S. National Health and Nutrition Examination Surveys, 1960-2014.

Authors:  Charles F Dillon; Michael H Weisman; Frederick W Miller
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

7.  Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.

Authors:  Yesica Garciafigueroa; Brett E Phillips; Carl Engman; Massimo Trucco; Nick Giannoukakis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

Review 8.  Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.

Authors:  María E Mejía-León; Ana M Calderón de la Barca
Journal:  Nutrients       Date:  2015-11-06       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.